Stock Splits
KALA BIO Implements 1-for-50 Reverse Stock Split, Reducing Outstanding Shares from 929.5 Million to 18.6 Million
KALA BIO executed a 1-for-50 reverse stock split to meet Nasdaq listing requirements and consolidate its capital structure, effective May 11, 2026.
NeuroOne Regains Compliance with Nasdaq Minimum Bid Price Requirement
NeuroOne Medical Technologies Corporation announced it has regained compliance with Nasdaq's minimum bid price rule following a 1-for-6 reverse stock split, ensuring its continued listing on the Nasdaq Capital Market.
Aditxt Implements 1-for-113 Reverse Stock Split to Maintain Nasdaq Listing
Aditxt Inc. is executing a dramatic reverse stock split to regain compliance with Nasdaq's minimum bid price requirement, a critical move for maintaining its public market presence.
Bollinger Innovations Announces 1-for-250 Reverse Stock Split to Maintain Nasdaq Listing
Bollinger Innovations will implement a drastic reverse stock split to regain compliance with Nasdaq's minimum bid price requirement, significantly reducing outstanding shares from 126.2 million to approximately 505,000.
NeuralBase AI Announces 5-for-1 Stock Split to Enhance Investor Accessibility and Market Liquidity
NeuralBase AI Ltd. is implementing a 5-for-1 forward stock split to make shares more accessible to retail investors and improve market liquidity while maintaining shareholder value.
Bollinger Innovations Announces 1-for-250 Reverse Stock Split to Meet Nasdaq Compliance
Bollinger Innovations, Inc. (NASDAQ: BINI) is set to execute a 1-for-250 reverse stock split to comply with Nasdaq's minimum bid price requirement, a move that will significantly reduce its outstanding shares.
Healthcare Triangle, Inc. Announces 1-for-249 Reverse Stock Split to Meet Nasdaq Compliance
Healthcare Triangle, Inc. is implementing a 1-for-249 reverse stock split to increase its share price and comply with Nasdaq's minimum bid price requirement, a strategic move to maintain its market listing.
Calidi Biotherapeutics Announces 1-for-12 Reverse Stock Split to Optimize Market Dynamics
Calidi Biotherapeutics Inc. (NYSE American: CLDI) will implement a 1-for-12 reverse stock split effective August 5, 2025, aiming to enhance market appeal and align with shareholder interests.
CNS Pharmaceuticals Inc. Announces 1-for-12 Reverse Stock Split
CNS Pharmaceuticals Inc. (NASDAQ: CNSP) will execute a 1-for-12 reverse stock split to consolidate shares and adjust equity awards, aiming for uniform impact among shareholders.
Fusion Fuel Green PLC Announces 1-for-35 Reverse Share Split to Regain Nasdaq Compliance
Fusion Fuel Green PLC's reverse share split aims to meet Nasdaq's minimum bid price requirement, impacting shareholders and the company's market position.
Fusion Fuel Green PLC Proposes Reverse Share Split to Meet Nasdaq Compliance
Fusion Fuel Green PLC announces its Annual General Meeting on June 25, 2025, featuring a vote on a reverse share split aimed at regaining Nasdaq compliance, highlighting the company's strategic moves towards sustainability and growth.
Oragenics Implements 1-for-30 Reverse Stock Split to Enhance Market Appeal
Biotechnology company Oragenics will execute a reverse stock split to improve its capital markets positioning and potentially attract long-term investors, consolidating 30 existing shares into one new share.
TransCode Therapeutics Implements 1-for-28 Reverse Stock Split to Maintain Nasdaq Compliance
TransCode Therapeutics will execute a reverse stock split to increase its per-share price and meet Nasdaq listing requirements, reducing outstanding shares from 23.3 million to approximately 833,620.
Femto Technologies Implements Dramatic 1-for-500 Reverse Stock Split to Maintain Nasdaq Listing
Femto Technologies has executed a significant reverse stock split to address Nasdaq's minimum bid price requirements, reducing its outstanding shares from approximately 299,848,784 to roughly 599,697 while maintaining its trading symbol.
Aclarion Implements 1-for-335 Reverse Stock Split to Maintain Nasdaq Listing
Healthcare technology company Aclarion announces a significant reverse stock split to meet Nasdaq's minimum bid price requirements, reducing its outstanding shares from 169.4 million to approximately 500,000.
Aclarion Implements 1-for-370 Reverse Stock Split to Maintain Nasdaq Listing
Healthcare technology company Aclarion announces a significant reverse stock split to boost share price and maintain Nasdaq compliance, reducing outstanding shares from 185 million to approximately 500,000.